日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell RNA-seq reveals immune cell heterogeneity and increased Th17 cells in human fibrotic skin diseases

单细胞RNA测序揭示人类纤维化皮肤疾病中免疫细胞异质性和Th17细胞增多

Cheng-Cheng Deng # ,Xue-Yan Xu # ,Yan Zhang # ,Long-Can Liu ,Xuan Wang ,Jun-Yi Chen ,Liu-Yi Yao ,Ding-Heng Zhu ,Bin Yang

An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid

托法替尼(一种口服 JAK1 和 JAK3 激酶抑制剂)治疗中国瘢痕疙瘩患者的开放标签、非对照、单组临床试验

Jun-Yi Chen, Qing-Lan Feng, Hui-Hui Pan, Ding-Heng Zhu, Ren-Liang He, Cheng-Cheng Deng, Bin Yang

Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases

单细胞RNA测序揭示人类纤维化皮肤疾病中成纤维细胞的异质性和间充质成纤维细胞的增加

Cheng-Cheng Deng #,Yong-Fei Hu #,Ding-Heng Zhu #,Qing Cheng,Jing-Jing Gu,Qing-Lan Feng,Li-Xue Zhang,Ying-Ping Xu,Dong Wang,Zhili Rong,Bin Yang

TRAF4 Promotes Fibroblast Proliferation in Keloids by Destabilizing p53 via Interacting with the Deubiquitinase USP10

TRAF4 通过与去泛素化酶 USP10 相互作用,破坏 p53 的稳定性,促进瘢痕疙瘩中的成纤维细胞增殖

Cheng-Cheng Deng, Ding-Heng Zhu, Yong-Jun Chen, Tao-Yuan Huang, Yang Peng, Si-Ya Liu, Ping Lu, Yao-Hua Xue, Ying-Ping Xu, Bin Yang, Zhili Rong